Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen.
Poole A, Karuppiah V, Hartt A, Haidar JN, Moureau S, Dobrzycki T, Hayes C, Rowley C, Dias J, Harper S, Barnbrook K, Hock M, Coles C, Yang W, Aleksic M, Lin AB, Robinson R, Dukes JD, Liddy N, Van der Kamp M, Plowman GD, Vuidepot A, Cole DK, Whale AD, Chillakuri C.
Poole A, et al. Among authors: lin ab.
Nat Commun. 2022 Sep 10;13(1):5333. doi: 10.1038/s41467-022-32811-1.
Nat Commun. 2022.
PMID: 36088370
Free PMC article.